期刊文献+

鲍氏不动杆菌的分布及耐药性分析 被引量:8

Distribution and antibiotic resistance of Acinetobacter baummanii
原文传递
导出
摘要 目的调查医院鲍氏不动杆菌分布及耐药性变化,为临床合理用药提供依据。方法收集2008年6月-2011年6月3所医院细菌室分离的鲍氏不动杆菌,采用纸片扩散法作药敏试验。结果 3年共分离鲍氏不动杆菌503株,分布率在呼吸科最高,其次为ICU,分别为27.24%、21.87%;痰标本分离的鲍氏不动杆菌最多见,占81.71%,其次是伤口分泌物占12.13%;鲍氏不动杆菌的分离率在3年内逐年增加,依次为19.50%、21.71%、29.28%;鲍氏不动杆菌对多种抗菌药物的耐药率均较高,对多数抗菌药物的耐药率>50.00%,耐药率<50.00%仅有多黏菌素B、头孢哌酮/舒巴坦、阿米卡星、妥布霉素、米诺环素。结论 3所医院鲍氏不动杆菌对多种抗菌药物具有耐药性,应根据药敏结果合理使用抗菌药物。 OBJECTIVE To analyze the distribution and antimicrobial resistance of Acinetobacter baummanii so as to provide basis for the clinical reasonable use of antibiotics.METHODS A.baummanii were collected in 3 hospitals from June 2008 to June 2011.Antimicrobial susceptibility testing was performed by disk-diffusion method.RESULTS A total of 503 A.baummanii were collected during 3 years.Of these isolates,137(27.24%) strains were from the department of respiratory,110 strains(21.87%) from intensive care unit.Most of the strains(81.71%)were isolated from sputum,followed by the wound secretions;the prevalence of A.baummanii was increasing during last 3 years,which were 19.50%,21.71%,and 29.28%,respectively;the results of susceptibility testing showed that the resistance rates were high to most antibiotics,the resistance rates to most antimicrobial agents were more than 50.0%,only the drug resistance rates to polymyxin B,cefoperazone/sulbactam,amikacin,tobramycin,and minocycline were less than 50.0%.CONCLUSION A.baummanii isolates show high resistance to multiple antibiotics,it is necessary to reasonably use antibiotics on the basis of drug susceptibility testing.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第22期5128-5130,共3页 Chinese Journal of Nosocomiology
关键词 鲍氏不动杆菌 抗菌药物 耐药性 Acinetobacter baummanii Antibiotics Drug resistance
  • 相关文献

参考文献5

二级参考文献34

共引文献120

同被引文献57

  • 1王金良.密切注视鲍曼不动杆菌的耐药发展趋势[J].中华检验医学杂志,2005,28(4):355-356. 被引量:194
  • 2马越,李景云,金少鸿.细菌耐药性监测分析中应注意的问题[J].中国抗生素杂志,2005,30(12):762-769. 被引量:41
  • 3中华人民共和国卫生部,医院感染诊断标准[s].北京:中华人民共和国卫生部,2001.
  • 4Gur D, Korten V. Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)producing acinetobacter baumanin :report from the Turkish SENTRY Program sites [J]. Med Microbiol, 2008,57 (12) : 1529-1532.
  • 5GarnachoMontero J, AmayaVillar R, et al. Multiresistant Acinetobacter baumannii infections: epidemiology and management[J]. Curr Opin Infect Dis, 2010, 23(4):332-339.
  • 6Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrugresistant Acinetobacter baumannii[J]. Nat Rev Microbiol, 2007,5(12):939-951.
  • 7Peleg A Y,Seifert H,Paterson D L.Acinetobacter baumannii:emergence of a suceessful pathogen[J].Clin Microbiol Rev,2008,21(3):538-582.
  • 8MunozPrice L S,Weistein R A.Acinetobacter infection[J].N Engl J Med,2008,358(12):1271-1281.
  • 9Peleg AY,Seifert H,Paterson DL.Acinetobacter baumannii:emergence of a successful pathogen[J].Clin Microbiol Rev,2008,21(3):538-582.
  • 10Mendes RE,Bell JM,Turnidge JD,et al.Emergence and widespread dissemination of OXA-23,-24/40and 58carbapenemases among Acinetobacter spp.in Asia-Pacific nations:report from the SENTRY Surveillance Program[J].J Antimicrob Chemother,2009,63(1):55-59.

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部